Bringing healthcare home: vision for patient-led healthcare
Laennec AI Limited, a pioneering medical AI company based in Cardiff, announces the successful completion of its pre-seed funding round. The company has secured investment from SFC Capital and OVC Ventures, along with grant funding from the Welsh Government, Innovate UK, and the National Institute for Health Research (NIHR). This combined support will accelerate the development of affordable medical devices, bringing healthcare closer to patients and ushering in a new era of self-care.
Empowering patients through technology and remote monitoring
Harnessing cutting-edge technology to revolutionise healthcare, we integrate advanced algorithms into a user-friendly mobile app, empowering patients to monitor chronic conditions from home while ensuring they are remotely monitored by clinicians. This innovation not only makes healthcare more accessible but also represents a significant step towards the future of medical care.
Addressing global healthcare challenges
Chronic diseases are leading causes of morbidity worldwide, especially in underserved areas with limited access to healthcare facilities. Traditional healthcare models struggle to meet the demands of growing populations and the increasing prevalence of chronic conditions. Our solution addresses these challenges by making advanced diagnostic tools accessible and affordable, reducing healthcare inequalities and improving patient outcomes.
The future of medical care: decentralisation and self-care
“We envision a world where advanced medical care begins at home, and with this funding, we’re one step closer to making that a reality for millions,” said Dr Jase John, MBBS, MPH, Co-Founder and CEO. “By empowering patients with innovative tools and ensuring they are remotely monitored by clinicians, we’re shaping the future of healthcare to be more accessible, personalised, and efficient. We are grateful to our investors and grant partners for their support in making this vision a reality.”
Dr Arathy Varghese, PhD, Co-Founder and CTO added, “It’s a step towards a healthcare model where patients are active participants in their care. By integrating advanced technology into self-care practices, we’re enabling earlier detection, continuous monitoring, and better disease management.”
Support from visionary investors and grant organisations
The investment from SFC Capital, OVC Ventures, Innovate UK, NIHR, and the Welsh Government underscores the transformative potential of this technology. Their support is a testament to the growing recognition of innovative solutions in advancing healthcare and the importance of making these advancements accessible to all.
Rebecca Evans, Cabinet Secretary for Economy, Energy and Planning at the Welsh Government, said: “The revolutionary work of Laennec AI Limited aligns with our vision to create and nurture a vibrant innovation culture, improving standards and services, including in healthcare. I am pleased we have been able to support this cutting-edge project via our SMART Flexible Innovation Support programme, and look forward to seeing it benefit medical professionals and patients alike in the near future.”
Adam Beveridge, Investment Associate at SFC Capital, said: “We’re excited to lead the investment, as we support the team on their mission to improve respiratory conditions like asthma by using innovative tools. Their passion for addressing this challenge truly stood out to us, and we can’t wait to see the impact of their technology.”
Harrison Faull, Managing Director of OVC Ventures, said: “This highly skilled team and transformative approach to diagnostics stood out to us immediately. Their technology has the potential to elevate patient care while significantly reducing the operational costs that challenge the NHS and healthcare systems worldwide. We look forward to helping the team scale their operations and drive meaningful improvements for patients globally whilst generating a substantial return for our investors.”
Call to action for healthcare providers and clinicians
As we continue to develop and refine our AI-powered medical devices, we invite healthcare providers, clinicians, and research institutions interested in advancing remote monitoring and patient-led care to connect with us. Whether you are in respiratory care or chronic disease management, partnering with Laennec AI offers a unique opportunity to bring innovative, patient-focused solutions to life.
About SFC Capital
SFC Capital is the UK’s most active seed-stage investor, providing seed capital and support to promising British start-ups. By combining leading investment funds with an angel syndicate, SFC Capital offers investors diversified exposure to high-potential SEIS and EIS-qualifying businesses. Since 2012, the firm has invested in over 450 start-ups and partnered with British Business Investments to support innovation across all UK regions.
About OVC Ventures
OVC Ventures provides angel investors with access to carefully selected, high-growth start-ups each month, each with the potential to significantly increase in valuation within 7–10 years. Through a strategic partnership with OpenVC, a leading fundraising platform, OVC Ventures reviews nearly 1,000 deals monthly to identify companies with scalability and long-term defensibility.
About SMART Flexible Innovation Support Programme
The SMART Flexible Innovation Support (SMART FIS) programme is a Welsh Government initiative aimed at driving innovation and growth within businesses across Wales. By offering flexible funding and bespoke support, the programme helps companies develop new products, processes, and services, fostering economic development and enhancing competitiveness in the region.
About Laennec AI Limited
Laennec AI Limited is a Cardiff-based medical AI company specialising in AI-driven solutions for chronic disease management. Committed to making healthcare accessible and affordable, the company combines medical expertise with advanced technology to transform patient care. For more details about our innovative solutions or partnership opportunities, please visit our website or reach out directly.
